Measuring vascularity of hypertrophic scars by dermoscopy: Construct validity and predictive ability of scar thickness change

血管性 医学 疤痕 增生性瘢痕 增生性瘢痕 红斑 超声波 外科 放射科
作者
Huan Deng,Cecilia W. P. Li-Tsang,Jingbo Li
出处
期刊:Skin Research and Technology [Wiley]
卷期号:26 (3): 369-375 被引量:5
标识
DOI:10.1111/srt.12812
摘要

Abstract Background Vascularity of hypertrophic scar is a key indicator of scar maturation and a vital parameter of evaluating effects of scar management interventions. This study aims to explore the construct validity of dermoscopy for measuring vascularity of hypertrophic scar and its predictive ability of scar thickness change. Methods Patients with hypertrophic scars were recruited for scar assessments at baseline and at one‐month follow‐up, which consisted of the Patient and Observer Scar Assessment Scale, DermaLab Combo, ultrasound and dermoscopy. Results Forty hypertrophic scars in the active proliferation stage were included in this study. The dermoscopic measurements based on color significantly discriminated the hypertrophic scars from the healthy skin ( P < .001). In addition, they showed moderate to strong correlations with the vascularity component of the Patient and Observer Scar Assessment Scale ( r = −.438, P < .01; r = −.461, P < .01; and r = −.437, P < .01) and the erythema value as measured by DermaLab Combo ( r = −.474, P < .01; r = −.603, P < .01; and r = −.498, P < .01). Weak to moderate correlations of the micro‐vessel percentage were observed with the vascularity of Patient and Observer Scar Assessment Scale ( r = .385, P < .01) and the erythema of DermaLab Combo ( r = .444, P < .01). For prediction of the scars with high risk of thickness change, the green value by dermoscopy was the strongest predictor (AUC = 0.738, P = .034, 95%CI = 0.570‐0.906). Conclusion Dermoscopy, which evaluates scar vascularity by measuring scar color and micro‐vessel percentage, could be used as an objective assessment tool to indicate scar maturation and identify scars with active proliferation.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
P4完成签到 ,获得积分10
1秒前
mimicyang发布了新的文献求助10
1秒前
1秒前
2秒前
搞怪白易发布了新的文献求助10
3秒前
浦肯野应助irisjlj采纳,获得10
4秒前
迟大猫应助通~采纳,获得10
6秒前
8秒前
9秒前
木槿花难开完成签到,获得积分10
10秒前
小巧念寒完成签到,获得积分10
13秒前
玉ER完成签到,获得积分10
15秒前
希望天下0贩的0应助wei采纳,获得10
15秒前
北枳完成签到 ,获得积分10
19秒前
地精术士完成签到,获得积分10
20秒前
浙江嘉兴完成签到,获得积分10
20秒前
我是站长才怪应助通~采纳,获得10
22秒前
shiyu完成签到,获得积分10
22秒前
Herman_Chen完成签到,获得积分10
29秒前
Zn应助牛文文采纳,获得10
31秒前
31秒前
32秒前
贤惠的白开水完成签到 ,获得积分10
32秒前
英姑应助林林林采纳,获得10
33秒前
科研小民工应助Anquan采纳,获得30
33秒前
cyt9999发布了新的文献求助10
34秒前
天天快乐应助好难啊采纳,获得10
35秒前
干净的烧鹅完成签到,获得积分10
36秒前
37秒前
37秒前
在人中发布了新的文献求助10
38秒前
38秒前
fls221完成签到,获得积分10
39秒前
Laity完成签到,获得积分10
41秒前
41秒前
健忘捕发布了新的文献求助10
41秒前
林林林发布了新的文献求助10
42秒前
ok完成签到 ,获得积分10
43秒前
乐乐应助wewe采纳,获得30
43秒前
43秒前
高分求助中
Continuum Thermodynamics and Material Modelling 3000
Production Logging: Theoretical and Interpretive Elements 2700
Ensartinib (Ensacove) for Non-Small Cell Lung Cancer 1000
Unseen Mendieta: The Unpublished Works of Ana Mendieta 1000
Bacterial collagenases and their clinical applications 800
El viaje de una vida: Memorias de María Lecea 800
Luis Lacasa - Sobre esto y aquello 700
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 有机化学 生物化学 物理 纳米技术 计算机科学 内科学 化学工程 复合材料 基因 遗传学 物理化学 催化作用 量子力学 光电子学 冶金
热门帖子
关注 科研通微信公众号,转发送积分 3528035
求助须知:如何正确求助?哪些是违规求助? 3108306
关于积分的说明 9288252
捐赠科研通 2805909
什么是DOI,文献DOI怎么找? 1540220
邀请新用户注册赠送积分活动 716950
科研通“疑难数据库(出版商)”最低求助积分说明 709851